inna-051
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2022 (NCT05255822)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Toll-like receptor 6AGONIST
TLR6 agonist
- Toll-like receptor 2AGONIST
TLR2 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07222670 | Phase 2 | Nov 10, 2025 | ENA Respiratory Pty Ltd |
| NCT05118763 | Phase 2 | Mar 1, 2022 | ENA Respiratory Pty Ltd |
| NCT05255822 | Phase 2 | Feb 28, 2022 | ENA Respiratory Pty Ltd, hVIVO Services Limited |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ENA Respiratory Pty Ltd | For profit | 3 | 3 | 1 | 2022 |
| hVIVO Services Limited | For profit | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1